| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Aleman | 236 | 67% |
| Examiner Bahena | 261 | 66% |
| Examiner Baria | 369 | 69% |
| Examiner Blanco | 439 | 85% |
| Examiner Blass | 7 | 0% |
| Examiner Cochran | 0 | 0% |
| Examiner Crowe | 0 | 0% |
| Examiner Dudden | 0 | 0% |
| Examiner Dukert | 400 | 86% |
| Examiner Edwards (SPE) | 103 | 67% |
| Examiner Flores | 1 | 0% |
| Examiner Ganesan | 327 | 87% |
| Examiner Gherbi | 532 | 91% |
| Examiner Highland | 91 | 74% |
| Examiner Hoban | 226 | 62% |
| Examiner Hu | 384 | 69% |
| Examiner Lopez | 292 | 74% |
| Examiner Mannan | 190 | 67% |
| Examiner Mathew | 266 | 77% |
| Examiner Matthews | 276 | 82% |
| Examiner Melcher | 0 | 0% |
| Examiner Mukul | 0 | 0% |
| Examiner Nerenberg | 0 | 0% |
| Examiner Patel | 184 | 79% |
| Examiner Preston | 220 | 83% |
| Examiner Prone | 254 | 56% |
| Examiner Rios | 1 | 0% |
| Examiner Sharma | 308 | 82% |
| Examiner Snow | 360 | 81% |
| Examiner Spencer | 43 | 33% |
| Examiner Thomas | 0 | 0% |
| Examiner Tyson (SPE) | 329 | 81% |
| Examiner Watkins | 183 | 58% |
| Examiner White | 6 | 17% |
| Examiner Willse | 235 | 68% |
| Examiner Wolf | 227 | 66% |
| Examiner Woznicki | 432 | 37% |
| Examiner Zimmerman | 263 | 76% |
| Art Unit 3774 | 7445 | 73% |
| Number | Class Description |
|---|---|
| 623 | Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor |
| 606 | Surgery |
| 601 | Surgery: kinesitherapy |
| 128 | Surgery |
| 600 | Surgery |
| 604 | Surgery |
| 424 | Drug, bio-affecting and body treating compositions |
| 701 | Data processing: vehicles, navigation, and relative location |
| 602 | Surgery: splint, brace, or bandage |
| 700 | Data processing: generic control systems or specific applications |
Art Unit 3774's grant rate is lower than that of Group 3770 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 3774, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.